Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03887182
Other study ID # APHP180679
Secondary ID 2018-A03239
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date September 1, 2020
Est. completion date December 2023

Study information

Verified date July 2022
Source Assistance Publique - Hôpitaux de Paris
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Auditory Processing Disorder (APD) affects 0.5-7% of the pediatric population. This disorder is responsible for a child's low hearing ability. The diagnosis of APD is difficult because of polymorphic symptoms possibly entangled with other difficulties (learning, communication, attention ...). There is currently no gold standard in the literature for diagnosing APD. Investigators opened multidisciplinary consultation for the children suspected of APD. The purpose of this study is to analyze the results of the multidisciplinary assessment performed on these children (audiometry, cortical auditory brainstem response (ABR), behavioral assessment, psychometric evaluation, genetic analysis) to the results of functional MRI (fMRI) at rest and in activation. The goal is to find radiological MRI-fMRI markers in these patients that improve the diagnosis of APD. Investigators will compare the f-MRI results between three groups of children in order to find specific radiological markers of APD : - group 1 : children diagnosed with an Auditory Processing Disorder (APD) - group 2 : children suspect of APD - group 3 : children without APD (controls)


Description:

The study will include a multidisciplinary consultation with: - Targeted behavioral assessment auditory processing disorder (APD): speech-in-noise perception, phonemic identification and discrimination, dichotic listening test, temporal processing tests, Random Gap Detection Threshold (RGDT) test. - Psychometric assessment: assessment of visual / auditory working memory, visual / auditory attention, study of cognitive functions. - Ear, Nose, Throat (ENT) examination with otoscopy, tonal and vocal audiometry and ABR recording. - Genetic analysis - Cortical auditory evoked potential (AEP) recording, compared with the automatized cortical AEP recording on Hear Lab machine. The purpose of the study is looking for objective biomarkers of APD: - Compare EEG results with MRI-fMRI results - Analyze the cortical maturation of children who are fitted with hearings aids: second record of cortical APD performed one year after the fitting. - Compare the results after one year between group 1 ( with or without hearing aids) and children from group 2. - MRI-fMRI : to analyze the flow of perfusion, the DTI sequences, and the blood oxygen level-dependent (BOLD) effect (fMRI) With this multidisciplinary evaluation, the investigators wish to improve the diagnosis of APD in suspected children by associating clinical, radiological, electro-physiological and genetic criteria. Better understanding and more accurate diagnosis of APD's will improve the care management of these children.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 45
Est. completion date December 2023
Est. primary completion date December 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 7 Years to 18 Years
Eligibility Inclusion Criteria Group 1 & 2: : - 7 to 18 years old - selected following multidisciplinary consultation whether the diagnosis is confirmed (group G1) or not (group G2). - Signed consent of both parents - Affiliated with a health insurance plan Inclusion Criteria Group 3: - 7 to 18 years old - do not present any known hearing pathology - Signed consent of both parents - Affiliated with a health insurance plan Exclusion Criteria: - Require general anesthesia for MRI - Contraindication to MRI - Hearing aids for more than three months prior to inclusion in the study - Require sedation specifically for research

Study Design


Intervention

Diagnostic Test:
functional MRI
Additional sequence (DTI) and functional MRI (fMRI) during the MRI which is done as part of the usual care
Automated Cortical Brainstem Auditory Evoked Potential
Automated Cortical Brainstem Auditory Evoked Potential correspond to a non-invasive EEG
Genetic:
whole exome sequencing
A study of all the DNA-encoding exons of the child/parent from a sample taken as part of the usual care
Diagnostic Test:
Standard Cortical Brainstem Auditory Evoked Potential
Standard Cortical Brainstem Auditory Evoked Potential correspond to a non-invasive EEG
multidisciplinary consultation
multidisciplinary consultation is composed of: an ENT consultation and audiometry a speech therapy assessment a psychometric evaluation

Locations

Country Name City State
France Necker Hospital Paris

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

References & Publications (24)

Anderson S, Chandrasekaran B, Yi HG, Kraus N. Cortical-evoked potentials reflect speech-in-noise perception in children. Eur J Neurosci. 2010 Oct;32(8):1407-13. doi: 10.1111/j.1460-9568.2010.07409.x. — View Citation

Barker MD, Kuruvilla-Mathew A, Purdy SC. Cortical Auditory-Evoked Potential and Behavioral Evidence for Differences in Auditory Processing between Good and Poor Readers. J Am Acad Audiol. 2017 Jun;28(6):534-545. doi: 10.3766/jaaa.16054. — View Citation

Bartel-Friedrich S, Broecker Y, Knoergen M, Koesling S. Development of fMRI tests for children with central auditory processing disorders. In Vivo. 2010 Mar-Apr;24(2):201-9. — View Citation

Belin P, Zatorre RJ, Lafaille P, Ahad P, Pike B. Voice-selective areas in human auditory cortex. Nature. 2000 Jan 20;403(6767):309-12. doi: 10.1038/35002078. — View Citation

Chermak GD, Bamiou DE, Vivian Iliadou V, Musiek FE. Practical guidelines to minimise language and cognitive confounds in the diagnosis of CAPD: a brief tutorial. Int J Audiol. 2017 Jul;56(7):499-506. doi: 10.1080/14992027.2017.1284351. Epub 2017 Feb 28. — View Citation

Cunningham J, Nicol T, Zecker S, Kraus N. Speech-evoked neurophysiologic responses in children with learning problems: development and behavioral correlates of perception. Ear Hear. 2000 Dec;21(6):554-68. doi: 10.1097/00003446-200012000-00003. — View Citation

de Wit E, Visser-Bochane MI, Steenbergen B, van Dijk P, van der Schans CP, Luinge MR. Characteristics of Auditory Processing Disorders: A Systematic Review. J Speech Lang Hear Res. 2016 Apr 1;59(2):384-413. doi: 10.1044/2015_JSLHR-H-15-0118. — View Citation

Demanez L, Dony-Closon B, Lhonneux-Ledoux E, Demanez JP. Central auditory processing assessment: a French-speaking battery. Acta Otorhinolaryngol Belg. 2003;57(4):275-90. — View Citation

Kim MJ, Jeon HA, Lee KM, Son YD, Kim YB, Cho ZH. Neuroimaging features in a case of developmental central auditory processing disorder. J Neurol Sci. 2009 Feb 15;277(1-2):176-80. doi: 10.1016/j.jns.2008.10.020. Epub 2008 Dec 6. — View Citation

Martin BA, Tremblay KL, Korczak P. Speech evoked potentials: from the laboratory to the clinic. Ear Hear. 2008 Jun;29(3):285-313. doi: 10.1097/AUD.0b013e3181662c0e. Erratum In: Ear Hear. 2008 Dec;29(6):979. — View Citation

Micallef LA. Auditory Processing Disorder (APD): Progress in Diagnostics So Far. A Mini-Review on Imaging Techniques. J Int Adv Otol. 2015 Dec;11(3):257-61. doi: 10.5152/iao.2015.1009. — View Citation

Moore DR, Ferguson MA, Edmondson-Jones AM, Ratib S, Riley A. Nature of auditory processing disorder in children. Pediatrics. 2010 Aug;126(2):e382-90. doi: 10.1542/peds.2009-2826. Epub 2010 Jul 26. — View Citation

Owen JP, Marco EJ, Desai S, Fourie E, Harris J, Hill SS, Arnett AB, Mukherjee P. Abnormal white matter microstructure in children with sensory processing disorders. Neuroimage Clin. 2013 Jun 23;2:844-53. doi: 10.1016/j.nicl.2013.06.009. eCollection 2013. — View Citation

Pluta A, Wolak T, Czajka N, Lewandowska M, Ciesla K, Rusiniak M, Grudzien D, Skarzynski H. Reduced resting-state brain activity in the default mode network in children with (central) auditory processing disorders. Behav Brain Funct. 2014 Sep 26;10(1):33. doi: 10.1186/1744-9081-10-33. — View Citation

Punch S, Van Dun B, King A, Carter L, Pearce W. Clinical Experience of Using Cortical Auditory Evoked Potentials in the Treatment of Infant Hearing Loss in Australia. Semin Hear. 2016 Feb;37(1):36-52. doi: 10.1055/s-0035-1570331. — View Citation

Purdy SC, Kelly AS, Davies MG. Auditory brainstem response, middle latency response, and late cortical evoked potentials in children with learning disabilities. J Am Acad Audiol. 2002 Jul-Aug;13(7):367-82. — View Citation

Sharma A, Dorman MF, Spahr AJ. Rapid development of cortical auditory evoked potentials after early cochlear implantation. Neuroreport. 2002 Jul 19;13(10):1365-8. doi: 10.1097/00001756-200207190-00030. — View Citation

Sharma A, Glick H, Campbell J, Biever A. CENTRAL AUDTIORY DEVELOPMENT IN CHILDREN WITH HEARING LOSS: CLINICAL RELEVANCE OF THE P1 CAEP BIOMARKER IN HEARING-IMPAIRED CHILDREN WITH MULTIPLE DISABILITIES. Hearing Balance Commun. 2013 Sep;11(3):10.3109/21695717.2013.812378. doi: 10.3109/21695717.2013.812378. — View Citation

Sharma A, Kraus N, McGee TJ, Nicol TG. Developmental changes in P1 and N1 central auditory responses elicited by consonant-vowel syllables. Electroencephalogr Clin Neurophysiol. 1997 Nov;104(6):540-5. doi: 10.1016/s0168-5597(97)00050-6. — View Citation

Sharma A, Martin K, Roland P, Bauer P, Sweeney MH, Gilley P, Dorman M. P1 latency as a biomarker for central auditory development in children with hearing impairment. J Am Acad Audiol. 2005 Sep;16(8):564-73. doi: 10.3766/jaaa.16.8.5. — View Citation

Sharma M, Purdy S C, Kelly A S. The contribution of speech-evoked cortical auditory evoked potentials to the diagnosis and measurement of intervention outcomes in children with auditory processing disorder. Semin Hear. 2014;35(1):51-64

Sharma M, Purdy SC, Kelly AS. Comorbidity of auditory processing, language, and reading disorders. J Speech Lang Hear Res. 2009 Jun;52(3):706-22. doi: 10.1044/1092-4388(2008/07-0226). Epub 2008 Dec 8. — View Citation

Thomsen T, Rimol LM, Ersland L, Hugdahl K. Dichotic listening reveals functional specificity in prefrontal cortex: an fMRI study. Neuroimage. 2004 Jan;21(1):211-8. doi: 10.1016/j.neuroimage.2003.08.039. — View Citation

Tomlin D, Rance G. Maturation of the Central Auditory Nervous System in Children with Auditory Processing Disorder. Semin Hear. 2016 Feb;37(1):74-83. doi: 10.1055/s-0035-1570328. — View Citation

* Note: There are 24 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary BOLD effect BOLD effect is measured during fMRI and compared between the 3 groups of patients up to 4 weeks
Secondary set disyllabic words (Fournier or Boorsma lists) Speech evaluation : set disyllabic words using the Fournier or Boorsma lists (the French equivalent of the. Peabody PBK test), depending on age up to 4 weeks
Secondary RapDys Speech evaluation up to 4 weeks
Secondary Random Gap Detection Test (RGDT) Speech evaluation up to 4 weeks
Secondary Dichotic listening test Speech evaluation up to 4 weeks
Secondary temporal pattern recognition test Speech evaluation up to 4 weeks
Secondary Test of Everyday Attention for Children (TEA-Ch test) Psychometric evaluation for children aged 7-12 years up to 4 weeks
Secondary Wechsler Intelligence Scale for Children (WISC-V) test Psychometric evaluation for children aged 13-18 years up to 4 weeks
Secondary Chromosomal analysis (group 1 only) Genetic analysis up to 12 months
Secondary Work Environment Scale (WES) sequencing (group 1 only) Genetic analysis up to 12 months
Secondary Measures of P1, N1, P2, N2 waves' Latencies Cortical Brainstem Auditory Evoked At inclusion day (visit 1) and at 12 months (group 1 and 2 only)
Secondary Measures of P1, N1, P2, N2 waves' amplitudes Cortical Brainstem Auditory Evoked At inclusion day (visit 1) and at 12 months (group 1 an 2 only)
Secondary Infusion Rate (MRI-ASL) Infusion Rate (MRI-ASL) is measured during MRI up to 4 weeks
Secondary tractography results (DTI sequence) tractography results (DTI sequence) is measured during MRI up to 4 weeks